ViewRay lands Japanese regulatory approval for MRI linac

By staff writers

March 15, 2018 -- Image-guided radiation therapy developer ViewRay has secured approval from the Japanese Ministry of Health, Labor, and Welfare to market MRIdian Linac, the company's linear accelerator-based MRI-guided radiation therapy system.

MRIdian Linac is the first MR linac to receive approval in Japan, according to ViewRay. This action follows the U.S. Food and Drug Administration's (FDA) 510(k) clearance of the machine in 2017. The Japanese ministry also approved ViewRay's MRIdian cobalt system in August 2016, which the company has since installed at two hospitals in Japan.

General trading company Itochu currently represents ViewRay in Japan.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking